A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil
Clinical trial NCT06715254 · TERMINATED
Trial details
- NCT number
- NCT06715254
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-23
- Primary completion
- 2023-11-30
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.